2012 National Clinical Conference On Cannabis Therapeutics
Unfortunately, The Weed Blog will probably not make it to this event. However, I know of a lot of activists that are planning on attending, and I figured it would be good to post something so that others can possibly attend. It sounds like there will be more medical marijuana information at this event than most other events combined.
The Seventh National Clinical Conference on Cannabis Therapeutics will be held April 26-28, 2012 at Loews Ventana Canyon Resort in Tucson, Arizona!
Friday, April 27, 2012
0800 – Welcome and Opening remarks – Al Byrne (Patients Out of Time), Donald Abrams, MD (UCSF)
0830 – Cannabis: Why is it Forbidden? – Mary Lynn Mathre, RN, MSN
0850 – Overview of the Endocannabinoid System – Vincenzo DiMarzo, PhD
0930 – The ECS and Neuropathic Pain – Andrea Hohmann, PhD
1000 – Break
1020 – The Role of the Endocanabinoid System in the Regulation of Stress, Mood and Anxiety – Matthew Hill, PhD
1050 – The ECS and Addiction – Greg Gerdeman, PhD
1110 – Are Some Diseases the Result of an Endocannabinoid Deficiency? – Ethan Russo, MD (invited)
1140 – Care and Feeding of the Endocannabinoid System – John McPartland, DO
1200 – Lunch
1330 – Raw Cannabis: A Dietary Essential Optimized Through Individualized Phytogenetics – William Courtney, MD
1400 – Beyond THC: Bringing Back CBD – Martin A. Lee
1420 – Cannabis as an Exit Drug – Amanda Reiman, PhD, MSW
1440 – The Ocular Endocannabinoid System – Melanie Kelly, PhD
1510 – The Use of Cannabis with Glaucoma – Gary Storck (glaucoma patient, Elvy Musikka (federal medical cannabis patient)
1530 – Break
1545 – Question & Answer from the Faculty
1630 – Day end
0850 – Phytocannabinoids in the Treatment of Breast Cancer and Glioma Cell Cancer – Cristina Sanchez, PhD
0930 – The Use of Cannabis for ALS – Greg Carter, MD & Cathy Jordan (patient)
1000 – Break
1020 – Can Cannabis Prevent Alzheimer’s Disease? – Gary Wenk, PhD
1050 – Empirical Rationales for the Possibility of Cannabis Therapeutics in Post Traumatic Stress – Christopher Fichtner, MD
1120 – Clinical Trials of Cannabis Use for Post Traumatic Stress Among Veterans – Sue Sisley, MD
1140 – Perils and Promising Possibilities with Cannabis and Schizophrenia – Christopher Fichtner, MD
1200 – Lunch
1330 – Research and Education on Cannabinoids: Update from Canada – Mark Ware, MD
1400 – Panel: The ECS and Clinical Implications for Health Care: Clint Werner (Moderator), Andrew Weil, MD, Julie Holland, MD, Melanie Dreher, RN, PhD
1530 – Break
1545 – Question & Answer from the Faculty
1630 – Day end
